Filing Details

Accession Number:
0001209191-13-035979
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-09 16:14:41
Reporting Period:
2013-07-05
Filing Date:
2013-07-09
Accepted Time:
2013-07-09 16:14:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1502917 Christiana Stamoulis C/O Vertex Pharmaceuticals Incorporated
130 Waverly St.
Cambridge MA 02139
Svp, Corp Strategy & Bus Devlp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-05 4,687 $34.57 45,399 No 4 M Direct
Common Stock Disposition 2013-07-05 1,300 $80.65 44,099 No 4 S Direct
Common Stock Disposition 2013-07-05 3,387 $81.42 40,712 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2013-07-05 4,687 $0.00 4,687 $34.57
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,688 2010-01-05 2019-10-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 939 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Ms. Stamoulis' company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $80.65 (range $80.25 to $80.99).
  3. Ms. Stamoulis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $81.42 (range $81.01 to $81.77).
  5. The option vests in 16 quarterly installments beginning on 10/05/2009.